BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34579191)

  • 21. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Protection conferred by commercial NDV live attenuated and double recombinant HVT vaccines against virulent California 2018 Newcastle disease virus (NDV) in chickens.
    Ferreira HL; Reilley AM; Goldenberg D; Ortiz IRA; Gallardo RA; Suarez DL
    Vaccine; 2020 Jul; 38(34):5507-5515. PubMed ID: 32591288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of binary ethylenimine-inactivated vaccines of Gianyar-1/AK/2014 virulent strain in protecting chickens against Tabanan-1/ARP/2017 virulent Newcastle disease virus isolates.
    Adi AAAM; Astawa INM; Putra IGAA
    Vet World; 2019 Jun; 12(6):758-764. PubMed ID: 31439989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-ovo Newcastle disease virus vaccine strain TS09-C protects commercial chickens against Newcastle disease in the presence of maternally derived antibodies.
    Fan S; Wu Y; Wang H; Shang Y; Luo Q; Zhang T; Zhang R; Zhang W; Luo L; Shao H; Wen G
    Poult Sci; 2020 May; 99(5):2438-2443. PubMed ID: 32359578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of genotype VII Newcastle disease virus (NDV) isolated from NDV vaccinated chickens, and the efficacy of LaSota and recombinant genotype VII vaccines against challenge with velogenic NDV.
    Roohani K; Tan SW; Yeap SK; Ideris A; Bejo MH; Omar AR
    J Vet Sci; 2015; 16(4):447-57. PubMed ID: 25643805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comparison of the onset of protection induced by Newcastle disease virus strain B1 and a fowl poxvirus recombinant Newcastle disease vaccine to a viscerotropic velogenic Newcastle disease virus challenge.
    King DJ
    Avian Dis; 1999; 43(4):745-55. PubMed ID: 10611990
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recombinant fowlpox viruses coexpressing chicken type I IFN and Newcastle disease virus HN and F genes: influence of IFN on protective efficacy and humoral responses of chickens following in ovo or post-hatch administration of recombinant viruses.
    Karaca K; Sharma JM; Winslow BJ; Junker DE; Reddy S; Cochran M; McMillen J
    Vaccine; 1998 Oct; 16(16):1496-503. PubMed ID: 9711795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pathogenicity and immunogenicity of different recombinant Newcastle disease virus clone 30 variants after in ovo vaccination.
    Ramp K; Topfstedt E; Wäckerlin R; Höper D; Ziller M; Mettenleiter TC; Grund C; Römer-Oberdörfer A
    Avian Dis; 2012 Mar; 56(1):208-17. PubMed ID: 22545548
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q; Spatz S; Li Y; Yang J; Zhao W; Zhang Z; Wen G; Garcia M; Zsak L
    Vaccine; 2017 Feb; 35(5):789-795. PubMed ID: 28052812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunity to avian pneumovirus infection in turkeys following in ovo vaccination with an attenuated vaccine.
    Worthington KJ; Sargent BA; Davelaar FG; Jones RC
    Vaccine; 2003 Mar; 21(13-14):1355-62. PubMed ID: 12615430
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection of chickens against hepatitis-hydropericardium syndrome and Newcastle disease with a recombinant Newcastle disease virus vaccine expressing the fowl adenovirus serotype 4 fiber-2 protein.
    Tian KY; Guo HF; Li N; Zhang YH; Wang Z; Wang B; Yang X; Li YT; Zhao J
    Vaccine; 2020 Feb; 38(8):1989-1997. PubMed ID: 31948818
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protection in specific pathogen free chickens with live avian metapneumovirus and Newcastle disease virus vaccines applied singly or in combination.
    Ganapathy K; Cox WJ; Gough RE; Cargill P; Montiel E; Jones RC
    Avian Pathol; 2007 Aug; 36(4):313-7. PubMed ID: 17620178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of protection and viral shedding following vaccination with Newcastle disease virus strains of different genotypes used in vaccine formulation.
    Wajid A; Basharat A; Bibi T; Rehmani SF
    Trop Anim Health Prod; 2018 Oct; 50(7):1645-1651. PubMed ID: 29728823
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of chickens infected with a recombinant virulent NDV clone expressing chicken IL4.
    Marcano VC; Susta L; Diel DG; Cardenas-Garcia S; Miller PJ; Afonso CL; Brown CC
    Microb Pathog; 2021 Oct; 159():105116. PubMed ID: 34339794
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of an infectious bursal disease virus intermediate vaccine in ovo.
    Coletti M; Del Rossi E; Franciosini MP; Passamonti F; Tacconi G; Marini C
    Avian Dis; 2001; 45(4):1036-43. PubMed ID: 11785875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a turkey herpesvirus double construct vaccine (HVT-ND-IBD) against challenge with different strains of Newcastle disease, infectious bursal disease and Marek's disease viruses.
    van Hulten MCW; Cruz-Coy J; Gergen L; Pouwels H; Ten Dam GB; Verstegen I; de Groof A; Morsey M; Tarpey I
    Avian Pathol; 2021 Feb; 50(1):18-30. PubMed ID: 33063529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant Avian Paramyxovirus Serotypes 2, 6, and 10 as Vaccine Vectors for Highly Pathogenic Avian Influenza in Chickens with Antibodies Against Newcastle Disease Virus.
    Tsunekuni R; Hikono H; Tanikawa T; Kurata R; Nakaya T; Saito T
    Avian Dis; 2017 Sep; 61(3):296-306. PubMed ID: 28957006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Protection against Different Genotypes of Newcastle Disease Viruses (NDV) Afforded by an Adenovirus-Vectored Fusion Protein and Live NDV Vaccines in Chickens.
    Ferreira HL; Miller PJ; Suarez DL
    Vaccines (Basel); 2021 Feb; 9(2):. PubMed ID: 33669907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.